ArticleOpen heart2026
Severe aortic stenosis detection using seismocardiography.
Article in Open heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite this, aortic valve replacement rates remain low for patients with severe AS due to challenges in identifying clinically significant AS in time. This has prompted the need to develop and investigate novel diagnostic modalities. The objective of this study was to develop and validate novel, non-invasive diagnostic algorithm leveraging seismocardiography (SCG) data to detect severe AS.
methodA device capable of collecting a single-lead ECG and a three-dimensional SCG signal using a microelectromechanical-based accelerometer was used to collect sensor data. Phase 1 data were collected for training and validation of an algorithm for AS detection. Phase 2 data were collected as a blinded independent test set with age-matched and sex-matched patients as controls.
resultsIn phase 1 of the study, 115 subjects (n=56 AS patients and n=59 controls; mean age 73.8±10.4 years) were collected for training and validation of an algorithm for AS detection. Once model development was complete, the frozen model was then evaluated in a fully independent, single blinded phase 2 cohort of 99 subjects (n=50 AS patients and n=49 controls; mean age 76.8±6.4 years) for final analysis. The algorithm accurately classified 89 out of 99 patients, with four true AS cases misclassified as controls and six true control cases misclassified as AS. The sensitivity, specificity and area under the curve of the model were 92% (95% CI 84.5% to 99.5%), 87.8% (95% CI 78.6% to 96.9%), and 96% (95% CI 91.9% to 99.9%), respectively.
conclusionsThis SCG-based algorithm to detect severe AS demonstrated high sensitivity and specificity when tested in a blinded, age-matched and sex-matched cohort. These findings suggest that this technology may hold potential as a low-cost diagnostic tool for the detection of AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.